Cutaneous and Mucocutaneous Leishmaniasis

Cutis

Volumn 57, Issue 1, 1996, Pages 13-20

  Samady, Joseph A ^a   Janniger, Camila K ^a   Schwartz, Robert A ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMONY DERIVATIVE; KETOCONAZOLE; LEISHMANIA VACCINE; MEGLUMINE ANTIMONATE; METHYLBENZETHONIUM CHLORIDE; PAROMOMYCIN; STIBOGLUCONATE SODIUM;

CLINICAL FEATURE; CRYOSURGERY; DIFFERENTIAL DIAGNOSIS; HISTOPATHOLOGY; HUMAN; IMMUNOPROPHYLAXIS; INTRADERMAL DRUG ADMINISTRATION; INTRALESIONAL DRUG ADMINISTRATION; LASER SURGERY; LEISHMANIA; LIFE CYCLE; ORAL DRUG ADMINISTRATION; PARASITE VECTOR; REVIEW; SKIN LEISHMANIASIS; TOPICAL DRUG ADMINISTRATION;

CHILD; DIAGNOSIS, DIFFERENTIAL; HUMANS; LEISHMANIASIS, CUTANEOUS; LEISHMANIASIS, MUCOCUTANEOUS;

EID: 0030023144     PISSN: 00114162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (73)

1. Kim YA, Schwartz RA; The influence of migration and travel. United States of America. In, Global Dermatology. Diagnosis and Management According to Geography, Climate, and Culture (Millikan LE, Parish LC, eds), pp 45-50. Berlin, Springer-Verlag, 1994.
2. Melby PC, Kreutzer RD, McMahon-Pratt D, et al: Cutaneous leishmaniasis: review of 59 cases seen at the National Institutes of Health. Clin Infect Dis 15: 924-937, 1992.
3. Goldman L: Types of American cutaneous leishmaniasis - dermatological aspects. A review. Am J Trop Med 27: 561-584, 1947.
4. Ross AJ, Schneider JS, Schwartz RA: An unusual granuloma in an American returning from India clinically resembling cutaneous leishmaniasis. Ariz Med 39: 376-377, 1982.
5. Rau RC, Dubin HV, Taylor WB: Leishmania tropica infections in travellers. Arch Dermatol 112: 197-201, 1976.
6. Koff AB, Rosen T: Treatment of cutaneous leishmaniasis. J Am Acad Dermatol 31: 693-708, 1994.
7. The Expert Committee: Control of the leishmaniases. Report of a WHO Expert Committee. WHO Tech Rep Ser 793: 1-158, 1990.
8. Kerr SF, McHugh CP, Dronen NO: Leishmaniasis in Texas: prevalence and seasonal transmission of Leishmania mexicana in Neotoma micropus. Am J Trop Med Hyg 53: 73-77, 1995.
9. Furner BB: Cutaneous leishmaniasis in Texas: report of a case and review of the literature. J Am Acad Dermatol 23: 368-371, 1090.
10. Goldman L: Pre-Columbian leishmaniasis [letter]. Arch Dermatol 119: 540, 1983.
11. Farah FS, Malak JA: Cutaneous leishmaniasis. Arch Dermatol 103: 467-474, 1971.
12. Hart DT: Cutaneous and visceral leishmaniasis: a historical perspective. Trans R Soc Trop Med Hyg 79: 740-741, 1985.
13. Moschella SL: Diseases of the mononuclear phagocytic system. In, Dermatology, 2nd ed (Moschella SL, Hurley HJ, eds), pp 972-983. Philadelphia, WB Saunders, 1985.
14. Norton SA, Frankenburg S, Klaus SN: Cutaneous leishmaniasis acquired during military service in the Middle East Arch Dermatol 128: 83-87, 1992.
15. Kohestany KA, Karimzad MA: Cutaneous leishmaniasis in Kabul: observations on a 'prolonged epidemic.' Ann Trop Med Parasitol 86: 361-371, 1992.
16. Grimaldi G Jr, Tesh RB, McMahon-Pratt D: A review of the geographic distribution and epidemiology of leishmaniasis in the New World. Am J Trop Med Hyg 41: 687-725, 1989.
17. Convit J, Kerdel-Vegas F: Disseminated cutaneous leishmaniasis. Arch Dermatol 91: 439-447, 1965.
18. Marsden PD: Mucosal leishmaniasis. Trans R Soc Trop Med Hyg 80: 859-876, 1986.
19. Anonymous: Leishmaniasis in the Americas. Epidemiol Bull 15: 8-13, 1994.
20. Sang DK, Njeru WK, Ashford RW: A possible animal reservoir for Leishmania tropica s.l. in Kenya. Ann Trop Med Parasitol 86: 311-312, 1992.
21. Nadim AF, Lezhnev LA, Ebadi R, et al: Infectious diseases. Manual for Practitioners and Students. Ministry of Public Health, Democratic Republic of Afghanistan, Kabul Medical Institute, Kabul, 1983, pp 248-257.
22. Barsky S, Storino W, Salgea K, et al: Cutaneous leishmaniasis. Arch Dermatol 114: 1354-1355, 1978.
23. Mebrahtu YB, Van Eys G, Guizani I, et al: Human cutaneous leishmaniasis caused by Leishmania donavani s.l. in Kenya. Trans R Soc Trop Med Hyg 87: 598-601, 1993.
24. Darmstadt GL, Lane AT: Picture of the month. Am J Dis Child 147: 1339-1340, 1993.
25. Sang DK, Njeru WK, Ashford RW: A zoonotic focus of cutaneous leishmaniasis due to Leishmania tropica at Utut, Rift Valley Province, Kenya. Trans R Soc Trop Med Hyg 88: 35-37, 1994.
26. Simpson MH, Mullins JF, Stone OJ: Disseminated anergic cutaneous leishmaniasis. Arch Dermatol 97: 301-303, 1968.
27. Convit J, Reyes O, Kerdel F: Disseminated anergic American leishmaniasis. Arch Dermatol 76: 213-217, 1957.
28. Goihman-Yahr M: American mucocutaneous leishmaniasis. Dermatol Clin 12: 703-712, 1994.
29. David C, Dimier-David L, Vargas F, et al: Fifteen years of cutaneous and mucocutaneous leishmaniasis in Bolivia: a retrospective study. Trans R Soc Trop Med Hyg 87: 7-9, 1993.
30. Rashid FR, Chunge CN, Oster CN, et al: Post-kala-azar dermal leishmaniasis occurring long after cure of visceral leishmaniasis in Kenya. East Afr Med J 63: 365-371, 1986.
31. Kumar PV, Sadeghi E, Torabi S: Kala azar with disseminated dermal leishmaniasis. Am J Trop Med Hyg 40: 150-153, 1989.
32. Herwaldt BL, Stokes SL, Juranek DD: American cutaneous leishmaniasis in U.S. travelers. Ann Intern Med 118: 779-784, 1993.
33. Kalter DC: Laboratory tests for the diagnosis and evaluation of leishmaniasis. Dermatol Clin 12: 37-50, 1994.
34. Skoryna-Karcz B, Chojecka-Adamska A, Adamski Z, et al: The case of cutaneous leishmaniasis - diagnostic difficulties. Przegl Dermatol 81: 544-547, 1994.
35. Navin TR, Arana FE, de Merida AM, et al: Cutaneous leishmaniasis in Guatemala: comparison of diagnostic methods. Am J Trop Med Hyg 42: 36-42, 1990.
36. Al-Jitawi SA, Farraj SE, Ramahi SA: Conventional scrapings versus fine needle aspiration cytology in the diagnosis of cutaneous leishmaniasis. Acta Cytol 39: 82-84, 1995.
37. Ohl CA, Hyams KC, Malone JD, et al: Leishmaniasis among Desert Storm veterans: a diagnostic and therapeutic dilemma. Milit Med 158: 726-729, 1993.
38. Farah FS, Klaus SN, Frankenburg S, et al: Protozoan and helminth infections. In, Dermatology in General Medicine, 4th ed (Fitzpatrick TB, Eisen AZ, Wolff K, et al, eds), pp 2772-2777. New York, McGraw-Hill, 1993.
39. Battistini G, Herrer A: Intradermo - reaccion en la leishmaniosis tegumentaria en el Peru. Rev Med Exp 4: 101-116, 1945.
40. Silveira FT, Lainson R, Shaw JJ, et al: Cutaneous leishmaniasis due to Leishmania (Leishmania) amazonensis in Amazonian Brazil, and the significance of a negative Montenegro skin-test in human infections. Trans R Soc Trop Med Hyg 85: 735-738, 1991.
41. Neogy AB, Nandy A, Chowdbury AB: Leishmanin test in post-kala-azar dermal leishmaniasis. Trans R Soc Trop Med Hyg 84: 58, 1990.
42. Rodriguez N, Guzman B, Rodas A, et al: Diagnosis of cutaneous leishmaniasis and species discrimination of parasites by PCR and hybridization. J Clin Microbiol 32: 2246-2252, 1994.
43. Lopez M, Inga R, Cangalaya M, et al: Diagnosis of Leishmania using the polymerase chain reaction: a simplified procedure for field work. Am J Trop Med Hyg 49: 348-356, 1993.
44. Aquilar CM, Reigosa A: Leishmaniasis cutánea del pene en un paciente de Venezuela. Med Cután Iber-Lat-Am 22: 380-382, 1994.
45. Biddlestone LR, Hepburn NC, McLaren KM: A clinico-pathological study of cutaneous leishmaniasis in British troops from Belize. Trans R Soc Trop Med Hyg 88: 672-676, 1994.
46. Blank C, Fuchs H, Rappersberger K, et al: Parasitism of epidermal Langerhans cells in experimental cutaneous leishmaniasis with Leishmania major. J Infect Dis 167: 418-425, 1993.
47. Barral A, Costa JML, Bittencourt AL, et al: Polar and subpolar diffuse cutaneous leishmaniasis in Brazil: clinical and immunopathologic aspects. Int J Dermatol 34: 474-479, 1995.
48. Sangueza OP, Sangueza JM, Stiller MJ, et al: Mucocutaneous leishmaniasis: a clinicopathologic classification. J Am Acad Dermatol 28: 927-932, 1993.
49. Manson P: Oriental Sore. In, Tropical Diseases, pp 442-445. London, Cassell, 1898.
50. Katzenellenbogen I: Vaccination against oriental sore. Arch Dermatol Syphilol 50: 239-242, 1944.
51. Berberian DA: Cutaneous leishmaniasis (oriental sore) - incubation period. Arch Dermatol Syphilol 50: 231-232, 1944.
52. Berberian DA Cutaneous leishmaniasis (oriental sore) - period of infectivity of saline suspensions of Leishmania tropics cultures kept at room temperature. Arch Dermatol Syphilol 50: 233, 1944.
53. Berberian DA: Cutaneous leishmaniasis (oriental sore) - vaccination against oriental sore with suspensions of killed Leishmania tropica. Arch Dermatol Syphilol 50: 234-236, 1944.
54. Monjour L, Suva OA, Vouldoukis I, et al: Immunoprophylaxis in cutaneous leishmaniasis. Lancet 340: 1098-1099, 1992.
55. Monjour L, Monjour E, Vouldoukis I, et al: Protective immunity against cutaneous leishmaniasis achieved by partly purified vaccine in a volunteer. Lancet 1: 1490, 1986.
56. Connell ND, Medina-Acosta E, McMaster WR, et al: Effective immunization against cutaneous leishmaniasis with recombinant bacille Calmette-Guérin expressing the Leishmania surface proteinase gp63. Proc Natl Acad Set USA 90: 11473-11477, 1993.
57. Marsden PD: Current concepts in parasitology - leishmaniasis. N Engl J Med 300: 350-352, 1979.
58. Biagi FF: La leishmaniasis tegumentaria mexicana y algunos datos médico - estadisticos de Escárcega, Camp Tesis, Universidad Nacional Autonoma de Mexico, 1953.
59. Herwaldt BL, Berman JD: Recommendations for treating leishmaniasis with sodium stibogluconate (Pentostam) and review of pertinent clinical studies. Am J Trop Med Hyg 46: 296-306, 1992.
60. Kellum RE: Treatment of cutaneous leishmaniasis with an intralesional antimonial drug (Pentostam). J Am Acad Dermatol 15: 620-622, 1986.
61. Memisoglu HR, Acar MA, Denli TG, et al: The usage of intralesional antimony compounds in cases with leishmania cutis. In, Book of Abstracts, 18th World Congress of Dermatology. Dermatology: Progress and Perspectives. New York City, June 12-18, 1992. Berlin, Springer International, 1992.
62. Saenz RE, Paz H, Berman JD: Efficacy of ketoconazole against Leishmania braziliensis panamensis cutaneous leishmaniasis. Am J Med 89:147-155, 1990.
63. Alsaleh QA, Dvorak R, Nanda A: Ketoconazole in the treatment of cutaneous leishmaniasis in Kuwait Int J Dermatol 34: 495-497, 1995.
64. Jolliffe DS: Cutaneous leishmaniasis from Belize - treatment with ketoconazole. Clin Exp Dermatol 11: 62-68, 1986.
65. Van Den Enden E, Van Gompel A, Stevens A, et al: Treatment of cutaneous leishmaniasis with oral itraconazole. Int J Dermatol 33: 285-286, 1994.
66. Baum KF, Berens RL: Successful treatment of cutaneous leishmaniasis with allopurinol after failure of treatment with ketoconazole. Gin Infect Dis 18: 813-815, 1994.
67. Barzilai A, Friedman J, Trau H: Treatment of cutaneous leishmaniasis with allopurinol. J Am Acad Dermatol 32: 518, 1995.
68. Krause G, Kroeger A: Topical treatment of American cutaneous leishmaniasis with paramomycin and methylbenzethonium chloride: a clinical study under field conditions in Ecuador. Trans R Soc Trop Med Hyg 88: 92-94, 1994.
69. Radentz WH: Leishmaniasis: clinical manifestations, immunologic responses, and treatment. J Assoc Milit Dermatol 13(2): 15-21, 1987.
70. Soto J, Hernandez N, Mejia H, et al: Successful treatment of New World cutaneous leishmaniasis with a combination of topical paromomycin/methylbenzethoniurn chloride and injectable meglumine antimonate. Clin Infect Dis 20: 47-51, 1995.
71. Bossiouny A, El Meshad M, Talaat M, et al: Cryosurgery in cutaneous leishmaniasis. Br J Dermatol 107: 467-474, 1982.
72. Junaid AJN: Treatment of cutaneous leishmaniasis with infrared heat. Int J Dermatol 25: 470-472, 1986.
73. Papetti G, Accetturi MP, Lombarde GA, et al: Leishmaniosi cutanea. Un caso a localizzazioni multiple. Chronica Dermatologica 5: 609-612, 1995.